Micropos Medical

Enabling accuracy in prostate cancer care

Micropos Medical is a Swedish medical device company that develops, manufactures, and sells technology enabling enhanced radiotherapy cancer treatment. Its product Raypilot® System, generates high precision as well as high efficiency through real-time tumour tracking in radiation treatment of prostate cancer. Raypilot is marketed in Europe and the US.

The Micropos Medical share is traded under the stock ticker MPOS on the Spotlight Stock Market.

For more information about the share, please visit Spotlight

---

IR CALENDAR

---

• 28 February 2022 – Year-end report and interim report Q4 2021
• 28 April 2022 – interim report Q1 2022
• 28 July 2022 – interim report Q2 2022
• 27 October 2022 – interim report Q3 2022
• 30 January 2023 – interim report Q4 2022

For additional information, please contact:
Thomas Lindström, CEO, Micropos Medical AB (publ)
+46-31-760 80 05, info@micropos.se

---